← Dashboard
Aug 17, 2026 02:19 PM ET
Catalyst
FDA/Bio
EYEPOINT SINKS ON DURAVYU PHASE 3 MISS - SEEKINGALPHA
Phase 3 miss triggers selloff, directly impacting biotech investment thesis.
What changed
Why it matters
Phase 3 miss triggers selloff, directly impacting biotech investment thesis.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →
← Dashboard
Aug 17, 2026 02:19 PM ET